Furthermore, dexmedetomidine has been shown to reduce lipopolysaccharide-induced sepsis-related acute kidney injury by activating the α7 nicotinic acetylcholine receptor, thereby reducing inflammation and apoptosis (Kang et al., 2018). The gene discussed is CHRNA7; the disease is Sepsis.